Bomb Report – Lifestyle
Author:
IRLAB Therapeutics
IRLAB: Invitation to the Interim Report for Q1 2026 Presentation and Webcast
April 30, 2026
IRLAB publishes the Annual Report for 2025
April 29, 2026
Nomination Committee’s proposal to the Board of Directors for IRLAB Therapeutics’ Annual General Meeting 2026
April 17, 2026
IRLAB to Present at Redeye Healthcare Day 2026
April 9, 2026
IRLAB to Present Clinical and Preclinical Data at The AD/PD(TM) 2026 – 20th International Conference on Alzheimer’s & Parkinson’s Diseases
March 17, 2026
IRLAB Participates in Life Science Day in Gothenburg on March 4, 2026
March 6, 2026
IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson’s Disease
March 5, 2026
IRLAB Publishes Full-Year Report for The Period January – December 2025
March 5, 2026